Curative Biotechnology, Inc. Stock Other OTC
Equities
CTYX
US20786Q2093
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 13.47M 18.37M |
---|---|---|---|---|---|
Net income 2022 | -5M -6.82M | Net income 2023 | -3M -4.09M | EV / Sales 2022 | - |
Net Debt 2022 | 1.07M 1.45M | Net Debt 2023 | 2.2M 3M | EV / Sales 2023 | - |
P/E ratio 2022 |
-2.09
x | P/E ratio 2023 |
-2.42
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.94% |
Managers | Title | Age | Since |
---|---|---|---|
I. Garr
CEO | Chief Executive Officer | 71 | 21-02-10 |
Paul M. Michael
CHM | Chairman | - | - |
Steve Chizzik
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Cary Sucoff
BRD | Director/Board Member | 71 | 22-05-11 |
Theresa Heah
BRD | Director/Board Member | 46 | 03-30 |
Lawrence Zaslow
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
+44.48% | 54.04B | |
+43.57% | 41.96B | |
-0.86% | 41.92B | |
-7.59% | 28.35B | |
+12.30% | 26.35B | |
-21.83% | 19B | |
+7.15% | 13B | |
+29.40% | 12.28B | |
+25.15% | 12.19B |